Health Trials

Iliac Artery Stenosis

3

Review clinical trials related to Iliac Artery Stenosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery Disease

The purpose of this study is to evaluate long-term safety and performance per the intended use of the S.M.A.R.T.™ Nitinol Stent System (SMART 120/150), S.M.A.R.T.™ CONTROL™ Nitinol Stent System (SMART CONTROL) and S.M.A.R.T.™ Flex Vascular Stent System (SMART Flex) in the treatment of iliac and femoropopliteal artery disease.

Participants needed: 240
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Cordis US Corp.Updated: Jan 14, 2026Locations: 1
Eligibility criteria

Subjects treated with SMART 120/150, SMART CONTROL or SMART Flex according to th... [+1]

Women who were pregnant or lactating at the time of the procedure. [+1]

Read more
Status: Not yet recruiting

A First-in-Man Clinical Trial to Evaluate the Safety and Feasibility of ICS-Elpis in Patients With Iliac Artery Stenosis or Occlusion Lesions

This trial is a prospective, single-center, first-in-man clinical trial to evaluate the feasibility, preliminary safety and effectiveness of the Bioresorbable Peripheral Balloon-Expandable Covered Scaffold System. 15 subjects are intended to be enrolled.

Participants needed: 15
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Biotyx Medical (Shenzhen) Co., Ltd.Updated: Dec 18, 2025Locations: 1
Eligibility criteria

Patients with stenosis or occlusion of the common iliac artery and/or external i... [+9]

Patients with previously stented target lesion. [+22]

Read more
Status: Recruiting

An Observational Study to Evaluate Safety, Performance, and Clinical Benefit of BeFlow

This international, observational multi-centre study of the device BFI will monitor technical success of the implantation, data regarding clinical performance, clinical benefit, as well as potential unknown side effects pursuant to the Intended Purpose.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Bentley InnoMed GmbHUpdated: Sep 19, 2025Locations: 2
Eligibility criteria

Patients with an indication for permanent intraluminal placement in iliac arteri... [+2]

Patients with any contraindication according to the IFU [+1]

Read more